- Report
- December 2025
- 150 Pages
Germany
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
India
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
India
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Japan
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
Japan
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
China
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2025
- 150 Pages
China
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- December 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- November 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- August 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- March 2024
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- January 2024
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- May 2023
- 150 Pages
Global
From €3394EUR$3,850USD£2,960GBP
€4276EUR$4,850USD£3,729GBP
- Report
- June 2023
- 127 Pages
Africa, Middle East
From €1322EUR$1,500USD£1,153GBP
- Report
- June 2023
- 347 Pages
Global
From €3174EUR$3,600USD£2,768GBP
- Report
- June 2023
- 107 Pages
North America
From €1322EUR$1,500USD£1,153GBP
- Report
- June 2023
- 127 Pages
Asia Pacific
From €1322EUR$1,500USD£1,153GBP
- Report
- June 2023
- 125 Pages
Europe
From €1322EUR$1,500USD£1,153GBP
- Report
- November 2022
- 105 Pages
North America
From €1322EUR$1,500USD£1,153GBP
- Report
- November 2022
- 303 Pages
Global
From €3174EUR$3,600USD£2,768GBP

The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less Read more